Clinical Trials on Regeneration in China

Total 266 results

Shanghai Refreshgene Technology Co., Ltd.

Recruiting

Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients

Neovascular Age-related Macular Degeneration

China
Shanghai General Hospital, Shanghai Jiao Tong University...
Shanghai Zhongshan Hospital; Shanghai 10th People's Hospital; Eye & ENT Hospital... and other collaborators

Unknown

Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD (ARTIS)

Neovascular Age-related Macular Degeneration

China
First Affiliated Hospital of Chongqing Medical...

Enrolling by invitation

Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD (IIT-A)

Exudative Age-Related Macular Degeneration

China
Huabo Biopharm Co., Ltd.

Completed

A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
AskGene Pharma, Inc.
Suzhou Aosaikang Biopharmaceutical Co., Ltd.

Recruiting

A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Peking University People's Hospital

Completed

Bevacizumab for Neovascular Age-related Macular Degeneration

Exudative Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

A Study of Longer Interval of IVT IBI302 in Subjects With nAMD

Neovascular Age-related Macular Degeneration

China
Shanghai General Hospital, Shanghai Jiao Tong University...
Innostellar Biotherapeutics

Active, not recruiting

Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China
RemeGen Co., Ltd.

Recruiting

Efficacy and Safety of RC28-E Versus Aflibercept

Wet Age-related Macular Degeneration

China
Smilebiotek Zhuhai Limited

Recruiting

QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration

Intermediate Age-Related Macular Degeneration

China
Sinocelltech Ltd.

Recruiting

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Wet Age-related Macular Degeneration

China
RemeGen Co., Ltd.

Completed

Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Chinese Academy of Sciences
Beijing Tongren Hospital

Unknown

Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

Dry Age-related Macular Degeneration

China
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD

Neovascular Age-related Macular Degeneration

China
RemeGen Co., Ltd.

Completed

Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration

Wet Age-Related Macular Degeneration

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Unknown

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Peking University

Completed

Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration

Age-related Macular Degeneration

China
Youxin Chen

Recruiting

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

A Study of IBI302 in Patients With nAMD

Neovascular Age-related Macular Degeneration

China
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Qilu Pharmaceutical Co., Ltd.

Completed

A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
AnewPharma
Renmin Hospital of Wuhan University

Unknown

Safety and Tolerability of Oral CM082 in Patients With wAMD

Age-Related Macular Degeneration

China
Lee's Pharmaceutical Limited

Unknown

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

AMD

China
Chengdu Origen Biotechnology Co., Ltd.

Not yet recruiting

Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Suspended

Evaluation of IBI302 Injection in nAMD or DME

Diabetic Macular Edema | Neovascular Age-related Macular Degeneration

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Observation of the Natural Course of Age-related Macular Degeneration

Dry Age-related Macular Degeneration | Macular Degeneration, Dry

China
Shanghai Henlius Biotech

Completed

Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD

Age Related Macular Degeneration

China
HuidaGene Therapeutics Co., Ltd.
Eye & ENT Hospital of Fudan University; Tianjin Medical University Eye Hospital

Recruiting

CRISPR/cas13-medIated RNA tarGeting tHerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Neovascular Age-related Macular Degeneration(nAMD)

China
Bio-Thera Solutions

Completed

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

Age-related Macular Degeneration

China
Peking University

Unknown

Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration

Age-related Macular Degeneration

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression (Aurora)

Age-Related Macular Degeneration

China
Chinese Academy of Sciences
The First Affiliated Hospital of Zhengzhou University

Unknown

Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells

Dry Age-related Macular Degeneration

China
Shanghai Eye Disease Prevention and Treatment Center
Beijing Friendship Hospital; Peking Union Medical College Hospital; Chinese University... and other collaborators

Completed

Development and Validation of a Deep Learning-based Myopia and Myopic Maculopathy Detection and Prediction System

Myopia | Myopic Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Head to Head Study of Anti-VEGF Treatment. (RELIANCE)

Age-related Macular Degeneration

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Wet Age-related Macular Degeneration

China
Shanghai Ninth People's Hospital Affiliated to...

Completed

Skin Dermal Regeneration After Stromal Vascular Fraction Transplantation (SDR-SVF)

Skin Regeneration

China
Innostellar Biotherapeutics Co.,Ltd

Recruiting

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Neovascular Age-Related Macular Degeneration

China
Qiang Zhou, MD. PhD.

Unknown

Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease (MLIDH)

Lumbar Spine Disc Degeneration

China
Beijing Tongren Hospital

Unknown

JY028 Single Vitreous Injection in a Phase 1 Clinical Trial in nAMD Patients

Macular Degeneration

China
Xiaodong Sun
Shanghai Zhongshan Hospital; Eye & ENT Hospital of Fudan University; Shanghai... and other collaborators

Unknown

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Age-related Macular Degeneration

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

Macular Degeneration | Age Related Macular Degeneration | AMD

China
Innostellar Biotherapeutics Co.,Ltd

Recruiting

Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

Neovascular Age-Related Macular Degeneration

China
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (EXTEND II)

Age Related Macular Degeneration

China
Beijing Tongren Hospital

Recruiting

Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration

Macular Degeneration

China

Clinical Trials on Regeneration in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations